Servier’s brain tumour treatment approved by US FDA
Servier Pharmaceuticals said the US FDA approved its treatment for a type of brain tumour, becoming the first drug to gain approval in the US for the disease. The drug, known as voranigo, is used to treat a form of brain cancer, called IDH-mutated grade 2 glioma, in patients who have undergone surgery.
BELIEBTE BEITRÄGE
Bluetongue outbreak in a Portuguese sheep farm has broken out
September 19, 2024
Austria says disaster fund to rise to 1 billion euros
September 19, 2024
Portugal gets help from Spain and Morocco in response to fires
September 19, 2024
Drought reduces Amazon rivers to historic lows
September 19, 2024
LIVEÜBERTRAGUNG